NovaBay Pharmaceuticals, Inc. (NBY) Dividend History

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for infections and skin conditions. The company is known for its research on novel antimicrobial compounds, particularly NVC-422, targeting ocular, skin, and mucous membrane infections. NovaBay aims to provide alternatives to traditional antibiotics, with a focus on anti-infective and dermatological products.

Dividend History

NovaBay Pharmaceuticals, Inc. currently does not pay dividends

Company News

  • Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%

    The global impetigo drugs market is expected to grow at a CAGR of 4.5% from 2023 to 2030, driven by factors such as the increasing incidence of impetigo, technological advancements in drug delivery, and the development of new antibiotics to combat antibiotic resistance.

    GlobeNewswire Inc.
    Featured Companies: PCVX
  • NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com

    NovaBay Pharmaceuticals is offering a 20% discount on its Avenova-branded eyecare products during Amazon Prime Day, aligning with National Dry Eye Awareness Month. The company aims to attract new and existing customers through this promotion, which comes amid growing sales of its products through online channels.

    Investing.com
    Featured Companies: AMZN
  • NovaBay Pharmaceuticals (NBY) Shows Fast-paced Momentum But Is Still a Bargain Stock

    NovaBay Pharmaceuticals (NBY) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

    Zacks Investment Research
  • Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

    ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. ZIM Integrated Shipping Services shares climbed 9.2% to $14.72 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers NovaBay Pharmaceuticals, Inc. (NYSE: NBY) gained 71.3% to $0.2810 in pre-market trading after gaining around 8% on Friday. NovaBay Pharmaceuticals and Sonoma Pharmaceuticals recently agreed to market Avenova-branded products in the European Union. Spectral AI, Inc. (NASDAQ: MDAI) gained 33.9% to $3.63 in pre-market trading after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4. TuanChe Limited (NASDAQ: TC) shares jumped 31.4% to $3.10 in pre-market trading after jumping more than 10% on Friday. Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) gained 24.1% to $0.7818 in pre-market trading. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) surged 17.7% to $0.5884 in pre-market trading. 60 Degrees ...

    Benzinga
    Featured Companies: ACON AEVA BJDX CPHI CRBP CYN GVH IMCC IVP MDAI PALI PHG PLAG SMX SXTP ZIM
  • Looking for Undervalued Penny Stocks? Use These Tips 

    Use these tips to find undervalued penny stocks The post Looking for Undervalued Penny Stocks? Use These Tips  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: BVS
Page data last updated 07/24/2025 04:23:19 UTC